Earth Science Tech (ETST) Long-Term Deferred Tax (2014 - 2026)
Earth Science Tech's (ETST) quarterly Long-Term Deferred Tax came in at $772294.0 in Q1 2026, up 306.88% on a QoQ basis from $189807.0 in Q1 2015.
Earth Science Tech (ETST) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 3 years of Long-Term Deferred Tax data on file, last reported at $772294.0 in Q1 2026.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $772294.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $772294.0 (changed N/A YoY) and the FY2026 annual result came in at $772294.0, changed N/A from the prior year.
- Long-Term Deferred Tax advanced to $772294.0 in Q1 2026, from $189807.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $772294.0 in Q1 2026 to a low of $772294.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Earth Science Tech | 34.80 Mn | 31.98 Mn | 6.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 578,170.00 |
| Mar 31, 2026 | 772,294.00 |
| Mar 31, 2015 | 189,807.00 |
| Mar 31, 2014 | 57,916.00 |